CFO exercised or converted 4,230.53 WST derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Feb 11, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Feb 13, 2026
CFOOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000105770-26-000007
Filed / recordedFeb 13, 2026, 2:37 AM UTCAdded to OQROOct 2, 2026, 12:29 PM UTC Data qualityVerified: identifiers matched exactly IssuerWEST PHARMACEUTICAL SERVICES INC Reporting personRobert W. Mcmahon Officer titleSVP & Chief Financial Officer TableNon-derivative (Table I) Transaction dateFeb 11, 2026 Acquired / disposedAcquired (A) Shares owned after4,230.525 Footnotes from the filing
- Restricted stock units convert into common stock on a one-for-one basis.
Around the same time
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.